GlassScriptPhysician profile
Saddad Toor
NPI 1649253998
$18,101.04
in general payments reported to CMS, 2019-2025
46 companies · $2,537 in 2025
The $2,537 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,504 · 2020: $1,994 · 2021: $4,568 · 2022: $2,095 · 2023: $3,473 · 2024: $1,930 · 2025: $2,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,937 · Travel and Lodging: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,936.60 |
| Travel and Lodging | $1,003.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,525.39 | 2019-2025 | Watchman Access System, Watchman Flx, Emblem Mri S-Icd |
| Biotronik INC. | $2,277.09 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Novartis Pharmaceuticals Corporation | $2,079.81 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,662.94 | 2019-2025 | Jardiance |
| Medtronic, INC. | $1,227.75 | 2021-2025 | Cobalt Dr Mri Surescan, Claria Mri Quad Crt-D Surescan, Micra |
| Amgen INC. | $904.57 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $533.53 | 2019-2023 | |
| Pfizer INC. | $505.22 | 2019-2025 | |
| Esperion Therapeutics, INC. | $478.52 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $458.15 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $386.43 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $385.09 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $332.56 | 2019-2025 | Eliquis, Camzyos |
| Biosense Webster, INC. | $288.94 | 2025 | Carto 3, Smartablatetm System Rf Generator |
| Medtronic Vascular, INC. | $240.84 | 2020 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $200.83 | 2020-2025 | Mitraclip |
| Abiomed | $140.61 | 2023 | Impella |
| Lundbeck LLC | $138.80 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $95.51 | 2019-2022 | |
| Amarin Pharma, INC. | $94.97 | 2019-2021 | |
| Novo Nordisk INC | $93.20 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.04 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $85.63 | 2019 | |
| Atricure, INC. | $77.19 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Scientific Affairs, LLC | $68.37 | 2022 | |
| Tactile Systems Technology INC | $67.86 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Lexicon Pharmaceuticals, INC. | $63.00 | 2023-2024 | Inpefa |
| Impulse Dynamics (USA) INC. | $58.81 | 2022-2025 | Optimizer, Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $53.83 | 2025 | |
| Alnylam Pharmaceuticals INC. | $52.65 | 2020-2023 | Onpattro |
| Baxter Healthcare | $51.09 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Medline Industries LP | $48.32 | 2023 | |
| Gilead Sciences, INC. | $43.63 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $40.55 | 2019 | |
| Cvrx, INC. | $36.77 | 2025 | Barostim Neo System |
| Heartflow, INC. | $30.08 | 2023 | Ffrct |
| Kowa Pharmaceuticals America, INC. | $29.13 | 2020 | |
| Irhythm Technologies, INC. | $19.68 | 2022 | |
| Cardiovascular Systems INC. | $18.84 | 2020 | |
| Ionis Pharmaceuticals, INC. | $18.51 | 2025 | Tryngolza |
| Lilly USA, LLC | $18.09 | 2025 | Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $18.00 | 2024 | Arcalyst |
| Preventice Services, LLC | $17.80 | 2019 | |
| Althera Pharmaceuticals LLC | $16.34 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saddad Toor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.